# Weican Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weican-medical

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Latest round: Angel (Apr 11, 2025)
- Investors on record: 4

## About

Based in Nanjing, China and founded in 2023, Weican (Nanjing) Medical Technology Development Co., Ltd., trading as Weican Medical, operates as a medical device manufacturer that mainly provides implantable drug delivery devices. In March 2026, Weican Medical raised a venture funding from Kaisheng Southeast Venture Capital, with participation from China Growth Capital and Nuoyu Capital.
The company focuses on the development and application of new technologies for minimally invasive implantable drug delivery devices. Its products include a series of implantable drug delivery devices (infusion ports), including multiple scenarios such as veins, arteries, peritoneal cavity, and dialysis access.
The company generates revenue by providing implantable drug delivery devices.
The venture funding raised in March 2026 will be used to further provide ample financial support for the company's core technology breakthroughs, capacity expansion, and market development.

## Funding rounds

- Angel, Apr 11, 2025 — Oriza Holdings, Nanjing Jiangbei New Area Sci-Tech Investment Group, Nuoyu Capital
- Seed, Jun 30, 2023 — China Growth Capital

## Investors

- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Seed
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Angel
- Nanjing Jiangbei New Area Sci-Tech Investment Group — Angel
- Nuoyu Capital — Angel